Piper Sandler Reiterates Overweight on DexCom, Raises Price Target to $95
ديكسكوم
DexCom, Inc. DXCM | 0.00 |
Piper Sandler analyst Matt O'Brien reiterates DexCom (NASDAQ:
DXCM) with a Overweight and raises the price target from $88 to $95.
Piper Sandler Reiterates Overweight on DexCom, Raises Price Target to $95
DexCom, Inc. DXCM | 0.00 |